Tilray Brands is trading at $3.48, down 6.33%, after first-quarter fiscal 2027 revenue of $257.1 million missed analyst expectations despite 23% year-over-year growth.
- Cannabis revenue fell to $56.1 million from $64.5 million a year earlier.
- Beverage revenue rose 82% to $101.5 million.
- Management reaffirmed its fiscal 2027 adjusted EBITDA outlook of $68 million to $75 million, but this did not offset the revenue shortfall as an immediate negative catalyst.